{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:09:18Z","timestamp":1777284558790,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As a new therapeutic technique based on digital technology, the commercialization and clinical application of digital therapeutics (DTx) are increasing, and the demand for expansion to new clinical fields is remarkably high. However, the use of DTx as a general medical component is still ambiguous, and this ambiguity may be owing to a lack of consensus on a definition, in addition to insufficiencies in research and development, clinical trials, standardization of regulatory frameworks, and technological maturity. In this study, we conduct an in-depth investigation and analysis of definitions, clinical trials, commercial products, and the regulatory status related to DTx using published literature, ClinicalTrials.gov, and web pages of regulatory and private organizations in several countries. Subsequently, we suggest the necessity and considerations for international agreements on the definition and characteristics of DTx, focusing on the commercialization characteristics. In addition, we discuss the status and considerations of clinical research, key technology factors, and the direction of regulatory developments. In conclusion, for the successful settlement of DTx, real-world evidence-based validation should be strengthened by establishing a cooperative system between researchers, manufacturers, and governments, and there should be effective technologies and regulatory systems for overcoming engagement barriers of DTx.<\/jats:p>","DOI":"10.1038\/s41746-023-00777-z","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:02:46Z","timestamp":1678449766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Digital therapeutics from bench to bedside"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-9494","authenticated-orcid":false,"given":"Changwon","family":"Wang","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-776X","authenticated-orcid":false,"given":"Chungkeun","family":"Lee","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-0310","authenticated-orcid":false,"given":"Hangsik","family":"Shin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.12793\/tcp.2019.27.1.6","volume":"27","author":"JY Chung","year":"2019","unstructured":"Chung, J. Y. Digital therapeutics and clinical pharmacology. Transl. Clin. Pharm. 27, 6\u201311 (2019).","journal-title":"Transl. Clin. Pharm."},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4103\/jfmpc.jfmpc_105_20","volume":"9","author":"A Dang","year":"2020","unstructured":"Dang, A., Arora, D. & Rane, P. Role of digital therapeutics and the changing future of healthcare. J. Fam. Med Prim. Care 9, 2207\u20132213 (2020).","journal-title":"J. Fam. Med Prim. Care"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"106319","DOI":"10.1016\/j.cmpb.2021.106319","volume":"209","author":"JS Hong","year":"2021","unstructured":"Hong, J. S., Wasden, C. & Han, D. H. Introduction of digital therapeutics. Comput Methods Prog. Biomed. 209, 106319 (2021).","journal-title":"Comput Methods Prog. Biomed."},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41746-020-00370-8","volume":"3","author":"NA Patel","year":"2020","unstructured":"Patel, N. A. & Butte, A. J. Characteristics and challenges of the clinical pipeline of digital therapeutics. NPJ Digit Med 3, 159 (2020).","journal-title":"NPJ Digit Med"},{"key":"777_CR5","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.2196\/jmir.4052","volume":"17","author":"SC Sepah","year":"2015","unstructured":"Sepah, S. C., Jiang, L. & Peters, A. L. Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. J. Med Internet Res 17, e92 (2015).","journal-title":"J. Med Internet Res"},{"key":"777_CR6","unstructured":"Digital Therapeutics Alliance. Digital Therapeutics Definition and Core Principles https:\/\/dtxalliance.org\/ (2019)."},{"key":"777_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jacbts.2016.03.009","volume":"1","author":"GA Van Norman","year":"2016","unstructured":"Van Norman, G. A. Drugs, devices, and the FDA: Part 2: An Overview of Approval Processes: FDA approval of medical devices.JACC Basic Transl. Sci. 1, 277\u2013287 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"777_CR8","unstructured":"EUROPEAN MEDICINES AGENCY. ICH Guideline E8 (R1) on General Considerations for Clinical Studies https:\/\/www.ema.europa.eu\/en\/ich-e8-general-considerations-clinical-studies (2022)."},{"key":"777_CR9","unstructured":"International Organization for Standardization. ISO 14155:2020\u2014Clinical Investigation of Medical Devices for Human Subjects\u2014Good Clinical Practice https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:14155:ed-3:v1:en (2020)."},{"key":"777_CR10","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.4103\/jfmpc.jfmpc_1252_20","volume":"9","author":"T Kamat","year":"2020","unstructured":"Kamat, T. Digital therapeutics can improve medication adherence in diabetes. J. Fam. Med Prim. Care 9, 5806\u20135807 (2020).","journal-title":"J. Fam. Med Prim. Care"},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.2196\/mhealth.6432","volume":"6","author":"I Ahmed","year":"2018","unstructured":"Ahmed, I. et al. Medication adherence apps: review and content analysis. JMIR Mhealth Uhealth 6, e62 (2018).","journal-title":"JMIR Mhealth Uhealth"},{"key":"777_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4258\/hir.2022.28.3.188","volume":"28","author":"KY Huh","year":"2022","unstructured":"Huh, K. Y., Oh, J., Lee, S. & Yu, K. S. Clinical evaluation of digital therapeutics: present and future. Health. Inf. Res. 28, 188\u2013197 (2022).","journal-title":"Health. Inf. Res."},{"key":"777_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.33069\/cim.2021.0028","volume":"3","author":"KM Park","year":"2021","unstructured":"Park, K. M., Lee, S. & Lee, E. Can digital therapeutics open a new era of sleep medicine. Chronobiol. Med. 3, 142\u2013148 (2021).","journal-title":"Chronobiol. Med."},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/add.15690","volume":"116","author":"R Vilardaga","year":"2021","unstructured":"Vilardaga, R. & McClernon, F. J. Regulatory oversight of behavioral digital therapeutics for addiction treatment: a commentary on Khadjesari et al. Addiction 116, 3287\u20133289 (2021).","journal-title":"Addiction"},{"key":"777_CR15","unstructured":"Valeria Burrone, L. G. & Bevan, A. Digital Therapeutics: Past Trends and Future Prospects https:\/\/www.evidera.com\/digital-therapeutics-past-trends-and-future-prospects\/ (2020)."},{"key":"777_CR16","unstructured":"National Library of Medicine(US). Indications Type of Digital Therapeutics in Clinicaltrials.gov https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=%22digital+therapeutics%22&cntry=&state=&city=&dist= (2022)."},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(18)30310-8","volume":"4","author":"CE Flik","year":"2019","unstructured":"Flik, C. E. et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol. Hepatol. 4, 20\u201331 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"777_CR18","doi-asserted-by":"publisher","first-page":"753736","DOI":"10.3389\/fpain.2021.753736","volume":"2","author":"J Ailani","year":"2021","unstructured":"Ailani, J., Rabany, L., Tamir, S., Ironi, A. & Starling, A. Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine. Front Pain. Res. (Lausanne) 2, 753736 (2021).","journal-title":"Front Pain. Res. (Lausanne)"},{"key":"777_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41746-021-00429-0","volume":"4","author":"SH Kollins","year":"2021","unstructured":"Kollins, S. H., Childress, A., Heusser, A. C. & Lutz, J. Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD. NPJ Digit Med. 4, 58 (2021).","journal-title":"NPJ Digit Med."},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jaip.2015.11.022","volume":"4","author":"RK Merchant","year":"2016","unstructured":"Merchant, R. K., Inamdar, R. & Quade, R. C. Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial. J. Allergy Clin. Immunol. Pr. 4, 455\u2013463 (2016).","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.jaip.2019.08.034","volume":"7","author":"BE Himes","year":"2019","unstructured":"Himes, B. E., Leszinsky, L., Walsh, R., Hepner, H. & Wu, A. C. Mobile health and inhaler-based monitoring devices for asthma management. J. Allergy Clin. Immunol. Pr. 7, 2535\u20132543 (2019).","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.2196\/mhealth.7362","volume":"6","author":"R Merchant","year":"2018","unstructured":"Merchant, R. et al. Digital health intervention for asthma: patient-reported value and usability. JMIR Mhealth Uhealth 6, e133 (2018).","journal-title":"JMIR Mhealth Uhealth"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.5665\/sleep.1872","volume":"35","author":"CA Espie","year":"2012","unstructured":"Espie, C. A. et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 35, 769\u2013781 (2012).","journal-title":"Sleep"},{"key":"777_CR24","doi-asserted-by":"publisher","unstructured":"Melvin, T., Kenny, D., Gewilling, M. & Fraser, D. Orphan medical devices and pediatric cardiology\u2014what interventionists in Europe need to know, and what needs to be done. Pediatr Cardiol 1\u20139 https:\/\/doi.org\/10.1007\/s00246-022-03029-1 (2022).","DOI":"10.1007\/s00246-022-03029-1"},{"key":"777_CR25","unstructured":"Food and Drug Administration(US). Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enforcement-policy-digital-health-devices-treating-psychiatric-disorders-during-coronavirus-disease (2020)."},{"key":"777_CR26","unstructured":"Ministry of Food and Drug Safety(Korea). Guideline on Review and Approval of Digital Therapeutics (For Industry) https:\/\/www.mfds.go.kr\/eng\/brd\/m_40\/view.do?seq=72624&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1 (2020)."},{"key":"777_CR27","unstructured":"Ministry of Food and Drug Safety(Korea). Guidelines on Safety and Performance Evaluation and Clinical Trials Plan of Digital Therapeutics for Alcohol Use Disorder(Korean) https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=14956&srchFr=&srchTo=&srchWord=%EB%94%94%EC%A7%80%ED%84%B8%EC%B9%98%EB%A3%8C%EA%B8%B0%EA%B8%B0&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1 (2021)."},{"key":"777_CR28","unstructured":"Ministry of Food and Drug Safety(Korea). Guidelines on Safety and Performance Evaluation and Clinical Trials Plan of Digital Therapeutics for Depressive Disorder (Korean) https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=15165&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1 (2022)."},{"key":"777_CR29","unstructured":"Ministry of Food and Drug Safety(Korea). Guidelines on Safety and Performance Evaluation and Clinical Trials Plan of Digital Therapeutics for Insomnia (Korean), https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=14955&srchFr=&srchTo=&srchWord=%EB%94%94%EC%A7%80%ED%84%B8%EC%B9%98%EB%A3%8C%EA%B8%B0%EA%B8%B0&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1 (2021)."},{"key":"777_CR30","unstructured":"Ministry of Food and Drug Safety(Korea). Guidelines on Safety and Performance Evaluation and Clinical Trials Plan of Digital Therapeutics for Nicotine Dependency of Smoking (Korean), https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=14957&srchFr=&srchTo=&srchWord=%EB%94%94%EC%A7%80%ED%84%B8%EC%B9%98%EB%A3%8C%EA%B8%B0%EA%B8%B0&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1 (2021)."},{"key":"777_CR31","unstructured":"Ministry of Food and Drug Safety(Korea). Guidelines on Safety and Performance Evaluation and Clinical Trials Plan of Digital Therapeutics for Panic Disorder (Korean) https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=15164&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1 (2022)."},{"key":"777_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5853\/jos.2019.01963","volume":"21","author":"MJ Choi","year":"2019","unstructured":"Choi, M. J., Kim, H., Nah, H. W. & Kang, D. W. Digital therapeutics: emerging new therapy for neurologic deficits after stroke. J. Stroke 21, 242\u2013258 (2019).","journal-title":"J. Stroke"},{"key":"777_CR33","doi-asserted-by":"publisher","unstructured":"Abbadessa, G. et al. Digital therapeutics in neurology. J. Neurol. 1\u201316, https:\/\/doi.org\/10.1007\/s00415-021-10608-4 (2021).","DOI":"10.1007\/s00415-021-10608-4"},{"key":"777_CR34","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.3349\/ymj.2022.63.S56","volume":"63","author":"SY Kim","year":"2022","unstructured":"Kim, S. Y. et al. Survey for government policies regarding strategies for the commercialization and globalization of digital therapeutics. Yonsei Med. J. 63, S56 (2022).","journal-title":"Yonsei Med. J."},{"key":"777_CR35","doi-asserted-by":"publisher","unstructured":"Crisafulli, S., Santoro, E., Recchia, G. & Trifir\u00f2, G. Digital therapeutics in perspective: from regulatory challenges to post-marketing surveillance. Front. Drug Safety Regulation 5, https:\/\/doi.org\/10.3389\/fdsfr.2022.900946 (2022).","DOI":"10.3389\/fdsfr.2022.900946"},{"key":"777_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/bjc.12286","volume":"61","author":"JR Carl","year":"2022","unstructured":"Carl, J. R. et al. Regulating digital therapeutics for mental health: opportunities, challenges, and the essential role of psychologists. Br. J. Clin. Psychol. 61, 130\u2013135 (2022).","journal-title":"Br. J. Clin. Psychol."},{"key":"777_CR37","doi-asserted-by":"publisher","first-page":"854665","DOI":"10.3389\/fmed.2022.854665","volume":"9","author":"A Prodan","year":"2022","unstructured":"Prodan, A. et al. Success factors for scaling up the adoption of digital therapeutics towards the realization of P5 medicine. Front Med (Lausanne) 9, 854665 (2022).","journal-title":"Front Med (Lausanne)"},{"key":"777_CR38","unstructured":"International Medical Device Regulators Forum. Machine Learning-enabled Medical Devices: Key Terms and Definitions https:\/\/www.imdrf.org\/documents\/machine-learning-enabled-medical-devices-key-terms-and-definitions (2022)."},{"key":"777_CR39","unstructured":"International Organization for Standardization. ISO 80601-2-61: Medical Electrical Equipment\u2014part 2-61: Particular Requirements for Basic Safety and Essential Performance of Pulse Oximeter Equipment https:\/\/www.iso.org\/standard\/67963.html (2017)."},{"key":"777_CR40","first-page":"47","volume":"2","author":"JY Sim","year":"2022","unstructured":"Sim, J. Y., Shin, J., Han, T., Kim, M. & Lee, J. Establishment of policies for the growth of the digital therapeutics industry based on a stakeholder survey. Health Insurance Rev. Assess. Serv. Res. 2, 47\u201356 (2022).","journal-title":"Health Insurance Rev. Assess. Serv. Res."},{"key":"777_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnhum.2018.00171","volume":"12","author":"P Afra","year":"2018","unstructured":"Afra, P. et al. Mobile Software as a Medical Device (SaMD) for the treatment of epilepsy: development of digital therapeutics comprising behavioral and music-based interventions for neurological disorders. Front Hum. Neurosci. 12, 171 (2018).","journal-title":"Front Hum. Neurosci."},{"key":"777_CR42","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/1545968320961114","volume":"34","author":"K Hutchinson","year":"2020","unstructured":"Hutchinson, K. et al. A music-based digital therapeutic: proof-of-concept automation of a progressive and individualized rhythm-based walking training program after stroke. Neurorehabil Neural Repair 34, 986\u2013996 (2020).","journal-title":"Neurorehabil Neural Repair"},{"key":"777_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97343-y","volume":"11","author":"A Luna","year":"2021","unstructured":"Luna, A. et al. Artificial intelligence application versus physical therapist for squat evaluation: a randomized controlled trial. Sci. Rep. 11, 18109 (2021).","journal-title":"Sci. Rep."},{"key":"777_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens, S., Dhunnoo, P. & Mesko, B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med 3, 118 (2020).","journal-title":"NPJ Digit Med"},{"key":"777_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1461444811410407","volume":"14","author":"J Jung","year":"2011","unstructured":"Jung, J., Chan-Olmsted, S., Park, B. & Kim, Y. Factors affecting e-book reader awareness, interest, and intention to use. N. Media Soc. 14, 204\u2013224 (2011).","journal-title":"N. Media Soc."},{"key":"777_CR46","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10796-020-10012-9","volume":"23","author":"A Elena-Bucea","year":"2020","unstructured":"Elena-Bucea, A., Cruz-Jesus, F., Oliveira, T. & Coelho, P. S. Assessing the role of age, education, gender and income on the digital divide: evidence for the European Union. Inf. Syst. Front. 23, 1007\u20131021 (2020).","journal-title":"Inf. Syst. Front."},{"key":"777_CR47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/1369118X.2014.891633","volume":"17","author":"M Haight","year":"2014","unstructured":"Haight, M., Quan-Haase, A. & Corbett, B. A. Revisiting the digital divide in Canada: the impact of demographic factors on access to the internet, level of online activity, and social networking site usage. Inf. Commun. Soc. 17, 503\u2013519 (2014).","journal-title":"Inf. Commun. Soc."},{"key":"777_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/01972243.2018.1438550","volume":"34","author":"N Bol","year":"2018","unstructured":"Bol, N., Helberger, N. & Weert, J. C. Differences in mobile health app use: a source of new digital inequalities. Inf. Soc. 34, 183\u2013193 (2018).","journal-title":"Inf. Soc."},{"key":"777_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3803\/EnM.2021.107","volume":"36","author":"M Kim","year":"2021","unstructured":"Kim, M. & Choi, H. J. Digital Therapeutics for Obesity and Eating-Related Problems. Endocrinol. Metab. (Seoul.) 36, 220\u2013228 (2021).","journal-title":"Endocrinol. Metab. (Seoul.)"},{"key":"777_CR50","unstructured":"Food and Drug Administration(US). Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/postmarket-surveillance-under-section-522-federal-food-drug-and-cosmetic-act (2022)."},{"key":"777_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/2168479018763591","volume":"52","author":"NA Dreyer","year":"2018","unstructured":"Dreyer, N. A. Advancing a framework for regulatory use of real-world evidence: when real is reliable. Therapeutic Innov. regulatory Sci. 52, 362\u2013368 (2018).","journal-title":"Therapeutic Innov. regulatory Sci."},{"key":"777_CR52","unstructured":"Federal Institute for Drug and Medical Devices(Germany). The Fast-Track Process for Digital Health Applications (DiGA) according to Section 139e SGB V. A Guide for Manufacturers, Service Providers and Users https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/EN\/MedicalDevices\/DiGA_Guide.html>(2020)."},{"key":"777_CR53","unstructured":"CONGRESS(US). S.3791\u2014Access to Prescription Digital Therapeutics Act of 2022 https:\/\/www.congress.gov\/bill\/117th-congress\/senate-bill\/3791\/text (2022)."},{"key":"777_CR54","unstructured":"Food and Drug Administration(US). 510(k) Premarket Notification https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPMN\/pmn.cfm (2022)."},{"key":"777_CR55","unstructured":"Digital Therapeutics Alliance. Product Library https:\/\/dtxalliance.org\/understanding-dtx\/product-library\/ (2022)."},{"key":"777_CR56","unstructured":"The Federal Institute for Drugs and Medical Devices (Germany). Digitale Gesundheitsanwendungen https:\/\/diga.bfarm.de\/de\/verzeichnis (2022)."},{"key":"777_CR57","unstructured":"Agoria and beMedTech. mHealth BELGIUM application https:\/\/mhealthbelgium.be\/nl\/alle-apps (2022)."},{"key":"777_CR58","doi-asserted-by":"publisher","unstructured":"Wizemann, T. Public health effectiveness of the FDA 510 (k) clearance process: balancing patient safety and innovation: workshop report. https:\/\/doi.org\/10.17226\/12960 (2010).","DOI":"10.17226\/12960"},{"key":"777_CR59","unstructured":"EUROPEAN DATA PROTECTION SUPERVISOR. Digital Therapeutics (DTx) https:\/\/edps.europa.eu\/press-publications\/publications\/techsonar\/digital-therapeutics-dtx_en (2022)."},{"key":"777_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat. Rev. Drug Discov. 9, 203\u2013214 (2010).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00777-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:07:51Z","timestamp":1678450071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1038\/s41746-023-00777-z","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare there is no conflict of interests. The views and opinions expressed are those of the authors and do not reflect those of the Ministry of Food and Drug Safety in Republic of Korea.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}